The FDAs warnings occur during skyrocketing demand for GLP-1 therapies to treat obesity and Type 2 diabetes
Anti aging: It can eliminate free radicals, prevent collagen degradation, thereby reducing wrinkles and improving skin elasticity
Liposomal glutathione and sublingual forms are often preferred for absorption
William Kennedy shares, "I would consider prescribing BPC-157 for patients with chronic soft tissue injuries, tendon or ligament damage, or delayed healing when conventional therapies have not produced the desired results
What changed in 20232026 (and why everyones confused) The peptide landscape shifted sharply between 2023 and 2026: the FDA restricted roughly 19 peptides in 2023, then in 2026 began reversing course but removed from the restricted list is not the same as FDA-approved. The timeline is worth knowing, because most of what youll read online is out of date: 2023 the restriction
For people without a deficiency, the evidence for additional benefit from injections is much weaker
![glp 1 drugs and blindness Zepbound Blindness Lawsuit [2026 Update]](https://laviemd.us/wp-content/webp-express/webp-images/uploads/2025/05/glp-issues.png.webp)
